CHRS (STOCKS)
Coherus Oncology, Inc. Common Stock
$2.040000
-0.070000 (-3.32%)
Prev close: $2.110000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Denny M. Lanfear
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $246.58M
- Employees
- 177
- P/E (TTM)
- -1.29
- P/B (TTM)
- 2.79
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.97B |
| Benefits Costs and Expenses | $456.68M |
| Cost Of Revenue | $993.73M |
| Costs And Expenses | $456.68M |
| Gross Profit | $975.55M |
| Nonoperating Income/Loss | $638.00K |
| Operating Expenses | $961.54M |
| Selling, General, and Administrative Expenses | $561.63M |
| Depreciation and Amortization | $56.48M |
| Other Operating Expenses | $343.44M |
| Operating Income/Loss | $14.01M |
| Income/Loss Before Equity Method Investments | $1.19M |
| Income/Loss From Continuing Operations After Tax | -$8.67M |
| Income/Loss From Continuing Operations Before Tax | $1.07B |
| Income Tax Expense/Benefit | $11.48M |
| Income Tax Expense/Benefit, Deferred | $3.57M |
| Interest Expense, Operating | $13.45M |
| Net Income/Loss | -$10.28M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$10.28M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.28M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.09 |
| Diluted Earnings Per Share | -$0.09 |
| Basic Average Shares | 350,801,000 |
| Diluted Average Shares | 351,250,000 |
| Assets | $1.05B |
| Current Assets | $594.34M |
| Noncurrent Assets | $456.53M |
| Fixed Assets | $227.12M |
| Intangible Assets | $187.13M |
| Other Non-current Assets | $42.28M |
| Liabilities | $615.03M |
| Current Liabilities | $273.33M |
| Accounts Payable | $134.82M |
| Other Current Liabilities | $138.52M |
| Noncurrent Liabilities | $341.70M |
| Long-term Debt | $138.76M |
| Other Non-current Liabilities | $202.94M |
| Equity | $435.84M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $435.84M |
| Liabilities And Equity | $1.05B |
| Net Cash Flow From Operating Activities | $86.11M |
| Net Cash Flow From Operating Activities, Continuing | $86.11M |
| Net Cash Flow From Investing Activities | -$39.42M |
| Net Cash Flow From Investing Activities, Continuing | -$39.42M |
| Net Cash Flow From Financing Activities | -$13.01M |
| Net Cash Flow From Financing Activities, Continuing | -$13.01M |
| Net Cash Flow | $33.68M |
| Net Cash Flow, Continuing | $33.68M |
| Comprehensive Income/Loss | -$10.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.28M |
| Other Comprehensive Income/Loss | $0.00 |